1. Home
  2. RCMT vs MXCT Comparison

RCMT vs MXCT Comparison

Compare RCMT & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCM Technologies Inc.

RCMT

RCM Technologies Inc.

HOLD

Current Price

$20.00

Market Cap

149.7M

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.07

Market Cap

160.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCMT
MXCT
Founded
1971
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
149.7M
160.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
RCMT
MXCT
Price
$20.00
$1.07
Analyst Decision
Strong Buy
Buy
Analyst Count
1
4
Target Price
$30.00
$7.50
AVG Volume (30 Days)
33.4K
623.7K
Earning Date
03-11-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.71
N/A
Revenue
$309,840,000.00
$34,419,000.00
Revenue This Year
$16.29
N/A
Revenue Next Year
$6.92
$11.16
P/E Ratio
$11.76
N/A
Revenue Growth
13.70
N/A
52 Week Low
$13.18
$1.11
52 Week High
$28.27
$4.90

Technical Indicators

Market Signals
Indicator
RCMT
MXCT
Relative Strength Index (RSI) 47.60 22.94
Support Level $19.65 $1.19
Resistance Level $21.06 $1.28
Average True Range (ATR) 0.69 0.08
MACD 0.01 -0.03
Stochastic Oscillator 44.63 12.50

Price Performance

Historical Comparison
RCMT
MXCT

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

Share on Social Networks: